SICK CELLS

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
INDIGO HILL STRATEGIES	—	8

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	7

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	7
Budget/Appropriations	Budget/Appropriations	7
Medicare/Medicaid	Medicare/Medicaid	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

Show 21 more cited filings

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · third_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · second_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

H.R. 5178119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R. 5178

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 721119th Congress

Sickle Cell Disease Comprehensive Care Act

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S.721

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

S. 735119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2026 · first_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: S. 735

H.R. 1796119th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

2025 · fourth_quarter · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text and reported amounts

Client expense: — · Firm income: $30,000

Matched citations: H.R 1796

Source: Senate LDA

SICK CELLS — Lobbying Disclosure | Poliscope